NVNI:NASDAQNvni Group Limited Analysis
Data as of 2026-05-25 - not real-time
$1.20
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Nvni Group Limited trades at $1.20, which sits just below its 20‑day SMA of $1.214 and 50‑day SMA of $1.241, indicating short‑term weakness, while the 200‑day SMA remains far higher at $3.28, underscoring a long‑term bearish trend. Technical indicators such as a bearish MACD (‑0.048 vs. signal ‑0.045) and a neutral RSI of 49 reinforce the downside bias, and the stock is hovering near its identified support at $0.96 with resistance around $1.43. Volume is increasing, but the 30‑day volatility of 77% and a beta of 2.2 reveal an extremely volatile, high‑beta profile that amplifies price swings. Fundamentally, the company posted a revenue decline of 2.5% to $196.7 M, a gross margin of 65% but an operating margin of only 4.8%, and a net loss margin of –57%, resulting in negative EPS (‑$2.39 trailing, ‑$0.20 forward). Cash balances of $13.5 M are dwarfed by $63.6 M of debt, and free cash flow is deeply negative at –$31.8 M, indicating liquidity strain. Despite these challenges, the price‑to‑sales ratio of 0.07 and a DCF‑derived fair value of $1.98 suggest the market may be discounting the stock by over 40%, with an implied upside of more than 560% to the consensus $8 target. However, the absence of dividends and a negative book value per share (‑$2.77) signal limited financial cushion.
Given the confluence of bearish technical signals, deteriorating earnings, high leverage, and extreme volatility, the stock presents a high‑risk profile, but its ultra‑low valuation multiples and substantial upside potential keep it on the radar for speculative investors seeking a turnaround play.
Given the confluence of bearish technical signals, deteriorating earnings, high leverage, and extreme volatility, the stock presents a high‑risk profile, but its ultra‑low valuation multiples and substantial upside potential keep it on the radar for speculative investors seeking a turnaround play.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below 20‑day and 50‑day SMAs
- Bearish MACD and high volatility
- Negative earnings and widening losses
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- DCF fair value above current price
- Low price‑to‑sales multiple
- Continued cash flow deficit and high debt
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Potential upside to $8 consensus target
- Strong gross margin indicating operational leverage
- Opportunity for market expansion in Brazil/Latin America
Key Metrics & Analysis
Financial Health
Revenue Growth-2.50%
Profit Margin-57.40%
P/E Ratio-6.0
ROA-4.51%
P/B Ratio-0.4
Op. Cash Flow$8.0M
Free Cash Flow$-31800750
Industry P/E39.5
Technical Analysis
TrendBearish
RSI49.2
Support$0.96
Resistance$1.43
MA 20$1.21
MA 50$1.24
MA 200$3.28
MACDBearish
VolumeIncreasing
Fear & Greed Index91.8
Valuation
Fair Value$1.98
Target Price$8.00
Upside/Downside566.67%
GradeUndervalued
TypeValue
Risk Assessment
Beta2.20
Volatility77.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.